Apoptosis, Bcl-2 family proteins and caspases: The ABCs of seizure-damage and epileptogenesis?

International Journal of Physiology, Pathophysiology and Pharmacology

Volumn 1, Issue 2, 2009, Pages 97-115

  Engel, Tobias ^a   Henshall, David C ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

Apoptosis; Epilepsy; Epileptogenesis; Hippocampal sclerosis; Necrosis; Programmed cell death

Indexed keywords

CASPASE; CASPASE 2; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN BCL XL;

APOPTOSIS; BIOCHEMISTRY; CELL DEATH; DNA FRAGMENTATION; EPILEPSY; EPILEPTOGENESIS; GENE EXPRESSION; GENE TARGETING; HIPPOCAMPUS; HUMAN; NEOCORTEX; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; PROTEIN TARGETING; REVIEW; SEIZURE; SIGNAL TRANSDUCTION;

EID: 76749107731     PISSN: None     EISSN: 19448171     Source Type: Journal    
DOI: None     Document Type: Review

References (126)

1. Chang BS and Lowenstein DH. Epilepsy. N Engl J Med 2003; 349: 1257-1266.
2. Vezzani A and Granata T. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 2005; 46: 1724-1743.
3. Sloviter RS. Hippocampal epileptogenesis in animal models of mesial temporal lobe epilepsy with hippocampal sclerosis: the importance of the "latent period" and other concepts. Epilepsia 2008; 49 Suppl 9: 85-92.
4. Scharfman HE. The neurobiology of epilepsy. Curr Neurol Neurosci Rep 2007; 7: 348-354.
5. Boison D. The adenosine kinase hypothesis of epileptogenesis. Prog Neurobiol 2008; 84: 249-262.
6. Pitkanen A and Lukasiuk K. Molecular and cellular basis of epileptogenesis in symptomatic epilepsy. Epilepsy Behav 2009; 14 Suppl 1: 16-25.
7. Cavalleri GL, Weale ME, Shianna KV, Singh R, Lynch JM, Grinton B, Szoeke C, Murphy K, Kinirons P, O'Rourke D, Ge D, Depondt C, Claeys KG, Pandolfo M, Gumbs C, Walley N, McNamara J, Mulley JC, Linney KN, Sheffield LJ, Radtke RA, Tate SK, Chissoe SL, Gibson RA, Hosford D, Stanton A, Graves TD, Hanna MG, Eriksson K, Kantanen AM, Kalviainen R, O'Brien T J, Sander JW, Duncan JS, Scheffer IE, Berkovic SF, Wood NW, Doherty CP, Delanty N, Sisodiya SM and Goldstein DB. Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case-control study. Lancet Neurol 2007; 6: 970-980.
8. Mathern GW, Babb TL and Armstrong DL. Hippocampal Sclerosis. In: Engel JJ, Pedley TA, editors. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven Publishers; 1997. p. 133-155.
9. Houser CR. Granule cell dispersion in the dentate gyrus of humans with temporal lobe epilepsy. Brain Res 1990; 535: 195-204.
10. Gorter JA, Goncalves Pereira PM, van Vliet EA, Aronica E, Lopes da Silva FH and Lucassen PJ. Neuronal cell death in a rat model for mesial temporal lobe epilepsy is induced by the initial status epilepticus and not by later repeated spontaneous seizures. Epilepsia 2003; 44: 647-658.
11. Kalviainen R, Salmenpera T, Partanen K, Vainio P, Riekkinen P and Pitkanen A. Recurrent seizures may cause hippocampal damage in temporal lobe epilepsy. Neurology 1998; 50: 1377-1382.
12. Tasch E, Cendes F, Li LM, Dubeau F, Andermann F and Arnold DL. Neuroimaging evidence of progressive neuronal loss and dysfunction in temporal lobe epilepsy. Ann Neurol 1999; 45: 568-576.
13. Bernasconi A, Tasch E, Cendes F, Li LM and Arnold DL. Proton magnetic resonance spectroscopic imaging suggests progressive neuronal damage in human temporal lobe epilepsy. Prog Brain Res 2002; 135: 297-304.
14. Fujikawa DG. Neuroprotective strategies in status epilepticus. In: Wasterlain CG, Treiman DM, editors. Status epilepticus: Mechanisms and management. Cambridge: MIT Press; 2006. p. 463-480.
15. Dube C, Richichi C, Bender RA, Chung G, Litt B and Baram TZ. Temporal lobe epilepsy after experimental prolonged febrile seizures: prospective analysis. Brain 2006; 129: 911-922.
16. Brandt C, Potschka H, Loscher W and Ebert U. N-methyl-D-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in kainate model of temporal lobe epilepsy. Neuroscience 2003; 118: 727-740.
17. Andre V, Ferrandon A, Marescaux C and Nehlig A. The lesional and epileptogenic consequences of lithium-pilocarpine-induced status epilepticus are affected by previous exposure to isolated seizures: effects of amygdala kindling and maximal electroshocks. Neuroscience 2000; 99: 469-481.
18. Jimenez-Mateos EM, Hatazaki S, Johnson MB, Bellver-Estelles C, Mouri G, Bonner C, Prehn JH, Meller R, Simon RP and Henshall DC. Hippocampal transcriptome after status epilepticus in mice rendered seizure damage-tolerant by epileptic preconditioning features suppressed calcium and neuronal excitability pathways. Neurobiol Dis 2008; 32: 442-453.
19. Bumanglag AV and Sloviter RS. Minimal latency to hippocampal epileptogenesis and clinical epilepsy after perforant pathway stimulation-induced status epilepticus in awake rats. J Comp Neurol 2008; 510: 561-580.
20. Mouri G, Jimenez-Mateos E, Engel T, Dunleavy M, Hatazaki S, Paucard A, Matsushima S, Taki W and Henshall DC. Unilateral hippocampal CA3-predominant damage and short latency epileptogenesis after intra-amygdala microinjection of kainic acid in mice. Brain Res 2008; 1213: 140-151.
21. Liou AKF, Clark RS, Henshall DC, Yin XM and Chen J. To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy: a review on the stress-activated signaling pathways and apoptotic pathways. Prog Neurobiol 2003; 69: 103-142.
22. Kerr JF, Wyllie AH and Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-257.
23. Taylor RC, Cullen SP and Martin SJ. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 2008; 9: 231-241.
24. Youle RJ and Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008; 9: 47-59.
25. Strasser A, Jost PJ and Nagata S. The many roles of FAS receptor signaling in the immune system. Immunity 2009; 30: 180-192.
26. Ashkenazi A and Herbst RS. To kill a tumor cell: the potential of proapoptotic receptor agonists. J Clin Invest 2008; 118: 1979-1990.
27. Yang E, Zha J, Jockel J, Boise LH, Thompson CB and Korsmeyer SJ. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 1995; 80: 285-291.
28. O'Connor L, Strasser A, O'Reilly LA, Hausmann G, Adams JM, Cory S and Huang DC. Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J 1998; 17: 384-395.
29. Wang K, Yin XM, Chao DT, Milliman CL and Korsmeyer SJ. BID: a novel BH3 domain-only death agonist. Genes Dev 1996; 10: 2859-2869.
30. Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG, Colman PM, Day CL, Adams JM and Huang DC. Differential Targeting of Prosurvival Bcl-2 Proteins by Their BH3-Only Ligands Allows Complementary Apoptotic Function. Mol Cell 2005; 17: 393-403.
31. Kroemer G, Galluzzi L and Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev 2007; 87: 99-163.
32. Cain K, Bratton SB and Cohen GM. The Apaf-1 apoptosome: a large caspase-activating complex. Biochimie 2002; 84: 203-214.
33. Schreiber SS, Tocco G, Najm I, Thompson RF and Baudry M. Cycloheximide prevents kainate-induced neuronal death and c-fos expression in adult rat brain. J Mol Neurosci 1993; 4: 149-159.
34. Sakhi S, Bruce A, Sun N, Tocco G, Baudry M and Schreiber SS. p53 induction is associated with neuronal damage in the central nervous system. Proc Natl Acad Sci USA 1994; 91: 7525-7529.
35. Morrison RS, Wenzel HJ, Kinoshita Y, Robbins CA, Donehower LA and Schwartzkroin PA. Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death. J Neurosci 1996; 16: 1337-1345.
36. Xiang H, Kinoshita Y, Knudson CM, Korsmeyer SJ, Schwartzkroin PA and Morrison RS. Bax involvement in p53-mediated neuronal cell death. J Neurosci 1998; 18: 1363-1373.
37. Pollard H, Charriaut-Marlangue C, Cantagrel S, Represa A, Robain O, Moreau J and Ben-Ari Y. Kainate-induced apoptotic cell death in hippocampal neurons. Neuroscience 1994; 63: 7-18.
38. Cheung EC, Melanson-Drapeau L, Cregan SP, Vanderluit JL, Ferguson KL, McIntosh WC, Park DS, Bennett SA and Slack RS. Apoptosis-inducing factor is a key factor in neuronal cell death propagated by BAX-dependent and BAX-independent mechanisms. J Neurosci 2005; 25: 1324-1334.
39. Weiss S, Cataltepe O and Cole AJ. Anatomical studies of DNA fragmentation in rat brain after systemic kainate administration. Neuroscience 1996; 74: 541-551.
40. Nagy Z and Esiri MM. Neuronal cyclin expression in the hippocampus in temporal lobe epilepsy. Exp Neurol 1998; 150: 240-247.
41. Henshall DC, Clark RS, Adelson PD, Chen M, Watkins SC and Simon RP. Alterations in bcl-2 and caspase gene family protein expression in human temporal lobe epilepsy. Neurology 2000; 55: 250-257.
42. Shinoda S, Schindler CK, Meller R, So NK, Araki T, Yamamoto A, Lan JQ, Taki W, Simon RP and Henshall DC. Bim regulation may determine hippocampal vulnerability after injurious seizures and in temporal lobe epilepsy. J Clin Invest 2004; 113: 1059-1068.
43. Henshall DC, Schindler CK, So NK, Lan JQ, Meller R and Simon RP. Death-associated protein kinase expression in human temporal lobe epilepsy. Ann Neurol 2004; 55: 485-494.
44. Xu S, Pang Q, Liu Y, Shang W, Zhai G and Ge M. Neuronal apoptosis in the resected sclerotic hippocampus in patients with mesial temporal lobe epilepsy. J Clin Neurosci 2007; 14: 835-840.
45. Schindler CK, Pearson EG, Bonner HP, So NK, Simon RP, Prehn JH and Henshall DC. Caspase-3 cleavage and nuclear localization of caspase-activated DNase in human temporal lobe epilepsy. J Cereb Blood Flow Metab 2006; 26: 583-589.
46. Uysal H, Cevik IU, Soylemezoglu F, Elibol B, Ozdemir YG, Evrenkaya T, Saygi S and Dalkara T. Is the cell death in mesial temporal sclerosis apoptotic? Epilepsia 2003; 44: 778-784.
47. Sloviter RS, Dean E, Sollas AL and Goodman JH. Apoptosis and necrosis induced in different hippocampal neuron populations by repetitive perforant path stimulation in the rat. J Comp Neurol 1996; 366: 516-533.
48. Bengzon J, Kokaia Z, Elmer E, Nanobashvili A, Kokaia M and Lindvall O. Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures. Proc Natl Acad Sci USA 1997; 94: 10432-10437.
49. Zhang LX, Smith MA, Li XL, Weiss SR and Post RM. Apoptosis of hippocampal neurons after amygdala kindled seizures. Brain Res Mol Brain Res 1998; 55: 198-208.
50. Akcali KC, Sahiner M and Sahiner T. The role of bcl-2 family of genes during kindling. Epilepsia 2005; 46: 217-223.
51. Kondratyev A, Sahibzada N and Gale K. Electroconvulsive shock exposure prevents neuronal apoptosis after kainic acid-evoked status epilepticus. Brain Res Mol Brain Res 2001; 91: 1-13.
52. Murphy B, Dunleavy M, Shinoda S, Schindler C, Meller R, Bellver-Estelles C, Hatazaki S, Dicker P, Yamamoto A, Koegel I, Chu X, Wang W, Xiong Z, Prehn J, Simon R and Henshall D. Bcl-w Protects Hippocampus during Experimental Status Epilepticus. Am J Pathol 2007; 171: 1258-1268.
53. Schauwecker PE. Complications associated with genetic background effects in models of experimental epilepsy. Prog Brain Res 2002; 135: 139-148.
54. Schauwecker PE. Role of genetic influences in animal models of status. Epilepsia 2007; 48 Suppl 8: 21-23.
55. Henshall DC, Sinclair J and Simon RP. Spatio-temporal profile of DNA fragmentation and its relationship to patterns of epileptiform activity following focally evoked limbic seizures. Brain Res 2000; 858: 290-302.
56. Henshall DC, Araki T, Schindler CK, Lan J-Q, Tiekoter K, Taki W and Simon RP. Activation of Bcl-2-associated death protein and counter-response of Akt within cell populations during seizure-induced neuronal death. J Neurosci 2002; 22: 8458-8465.
57. Shinoda S, Araki T, Lan JQ, Schindler CK, Simon RP, Taki W and Henshall DC. Development of a model of seizure-induced hippocampal injury with features of programmed cell death in the BALB/c mouse. J Neurosci Res 2004; 76: 121-128.
58. Fujikawa DG, Ke X, Trinidad RB, Shinmei SS and Wu A. Caspase-3 is not activated in seizure-induced neuronal necrosis with internucleosomal DNA cleavage. J Neurochem 2002; 83: 229-240.
59. Fujikawa DG, Shinmei SS, Zhao S and Aviles ER, Jr. Caspase-dependent programmed cell death pathways are not activated in generalized seizure-induced neuronal death. Brain Res 2007; 1135: 206-218.
60. Henshall DC, Chen J and Simon RP. Involvement of caspase-3-like protease in the mechanism of cell death following focally evoked limbic seizures. J Neurochem 2000; 74: 1215-1223.
61. Li T, Lu C, Xia Z, Xiao B and Luo Y. Inhibition of caspase-8 attenuates neuronal death induced by limbic seizures in a cytochrome c-dependent and Smac/DIABLO-independent way. Brain Res 2006; 1098: 204-211.
62. Chuang YC, Chen SD, Lin TK, Liou CW, Chang WN, Chan SH and Chang AY. Upregulation of nitric oxide synthase II contributes to apoptotic cell death in the hippocampal CA3 subfield via a cytochrome c/caspase-3 signaling cascade following induction of experimental temporal lobe status epilepticus in the rat. Neuropharmacology 2007; 52: 1263-1273.
63. Puig B and Ferrer I. Caspase-3-associated apoptotic cell death in excitotoxic necrosis of the entorhinal cortex following intraperitoneal injection of kainic acid in the rat. Neurosci Lett 2002; 321: 182-186.
64. Henshall DC, Bonislawski DP, Skradski SL, Araki T, Lan J-Q, Schindler CK, Meller R and Simon RP. Formation of the Apaf-1/cytochrome c complex precedes activation of caspase-9 during seizure-induced neuronal death. Cell Death Differ 2001; 8: 1169-1181.
65. Gervais FG, Xu D, Robertson GS, Vaillancourt JP, Zhu Y, Huang J, LeBlanc A, Smith D, Rigby M, Shearman MS, Clarke EE, Zheng H, Van Der Ploeg LH, Ruffolo SC, Thornberry NA, Xanthoudakis S, Zamboni RJ, Roy S and Nicholson DW. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloidbeta precursor protein and amyloidogenic A beta peptide formation. Cell 1999; 97: 395-406.
66. Viswanath V, Wu Z, Fonck C, Wei Q, Boonplueang R and Andersen JK. Transgenic mice neuronally expressing baculoviral p35 are resistant to diverse types of induced apoptosis, including seizure-associated neurodegeneration. Proc Natl Acad Sci USA 2000; 97: 2270-2275.
67. Henshall DC, Bonislawski DP, Skradski SL, Meller R, Lan J-Q and Simon RP. Cleavage of Bid may amplify caspase-8-induced neuronal death following focally evoked limbic seizures. Neurobiol Dis 2001; 8: 568-580.
68. Henshall DC, Skradski SL, Bonislawski DP, Lan JQ and Simon RP. Caspase-2 activation is redundant during seizure-induced neuronal death. J Neurochem 2001; 77: 886-895.
69. Henshall DC, Skradski SL, Meller R, Araki T, Minami M, Schindler CK, Lan JQ, Bonislawski DP and Simon RP. Expression and differential processing of caspases 6 and 7 in relation to specific epileptiform EEG patterns following limbic seizures. Neurobiol Dis 2002; 10: 71-87.
70. Liu XM, Pei DS, Guan QH, Sun YF, Wang XT, Zhang QX and Zhang GY. Neuroprotection of Tat-GluR6-9c against neuronal death induced by kainate in rat hippocampus via nuclear and non-nuclear pathways. J Biol Chem 2006; 281: 17432-17445.
71. Manno I, Antonucci F, Caleo M and Bozzi Y. BoNT/E prevents seizure-induced activation of caspase 3 in the rat hippocampus. Neuroreport 2007; 18: 373-376.
72. Narkilahti S, Jutila L, Alafuzoff I, Karkola K, Paljarvi L, Immonen A, Vapalahti M, Mervaala E, Kalviainen R and Pitkanen A. Increased expression of caspase 2 in experimental and human temporal lobe epilepsy. Neuromolecular Med 2007; 9: 129-144.
73. Persike DS, Cunha RL, Juliano L, Silva IR, Rosim FE, Vignoli T, Dona F, Cavalheiro EA and Fernandes MJ. Protective effect of the organotelluroxetane RF-07 in pilocarpine-induced status epilepticus. Neurobiol Dis 2008; 31: 120-126.
74. Narkilahti S, Pirttila TJ, Lukasiuk K, Tuunanen J and Pitkanen A. Expression and activation of caspase 3 following status epilepticus in the rat. Eur J Neurosci 2003; 18: 1486-1496.
75. Weise J, Engelhorn T, Dorfler A, Aker S, Bahr M and Hufnagel A. Expression time course and spatial distribution of activated caspase-3 after experimental status epilepticus: Contribution of delayed neuronal cell death to seizure-induced neuronal injury. Neurobiol Dis 2005; 18: 582-590.
76. Roy M, Hom JJ and Sapolsky RM. HSV-mediated delivery of virally derived anti-apoptotic genes protects the rat hippocampus from damage following excitotoxicity, but not metabolic disruption. Gene Ther 2002; 9: 214-219.
77. Narkilahti S, Nissinen J and Pitkanen A. Administration of caspase 3 inhibitor during and after status epilepticus in rat: effect on neuronal damage and epileptogenesis. Neuropharmacology 2003; 44: 1068-1088.
78. Narkilahti S and Pitkanen A. Caspase 6 expression in the rat hippocampus during epileptogenesis and epilepsy. Neuroscience 2005; 131: 887-897.
79. Yamamoto A, Murphy N, Schindler CK, So NK, Stohr S, Taki W, Prehn JH and Henshall DC. Endoplasmic reticulum stress and apoptosis signaling in human temporal lobe epilepsy. J Neuropathol Exp Neurol 2006; 65: 217-225.
80. Tomioka M, Shirotani K, Iwata N, Lee HJ, Yang F, Cole GM, Seyama Y and Saido TC. In vivo role of caspases in excitotoxic neuronal death: generation and analysis of transgenic mice expressing baculoviral caspase inhibitor, p35, in postnatal neurons. Brain Res Mol Brain Res 2002; 108: 18-32.
81. Verdaguer E, Garcia-Jorda E, Jimenez A, Stranges A, Sureda FX, Canudas AM, Escubedo E, Camarasa J, Pallas M and Camins A. Kainic acid-induced neuronal cell death in cerebellar granule cells is not prevented by caspase inhibitors. Br J Pharmacol 2002; 135: 1297-1307.
82. Yakovlev AG, Ota K, Wang G, Movsesyan V, Bao WL, Yoshihara K and Faden AI. Differential expression of apoptotic protease-activating factor-1 and caspase-3 genes and susceptibility to apoptosis during brain development and after traumatic brain injury. J Neurosci 2001; 21: 7439-7446.
83. Liu CL, Siesjo BK and Hu BR. Pathogenesis of hippocampal neuronal death after hypoxiaischemia changes during brain development. Neuroscience 2004; 127: 113-123.
84. Schotte P, Declercq W, Van Huffel S, Vandenabeele P and Beyaert R. Non-specific effects of methyl ketone peptide inhibitors of caspases. FEBS Lett 1999; 442: 117-121.
85. Knoblach SM, Alroy DA, Nikolaeva M, Cernak I, Stoica BA and Faden AI. Caspase inhibitor z-DEVD-fmk attenuates calpain and necrotic cell death in vitro and after traumatic brain injury. J Cereb Blood Flow Metab 2004; 24: 1119-1132.
86. Bizat N, Galas MC, Jacquard C, Boyer F, Hermel JM, Schiffmann SN, Hantraye P, Blum D and Brouillet E. Neuroprotective effect of zVAD against the neurotoxin 3-nitropropionic acid involves inhibition of calpain. Neuropharmacology 2005; 49: 695-702.
87. Kondratyev A and Gale K. Intracerebral injection of caspase-3 inhibitor prevents neuronal apoptosis after kainic acid-evoked status epilepticus. Brain Res Mol Brain Res 2000; 75: 216-224.
88. Lopez E, Pozas E, Rivera R and Ferrer I. Bcl-2, Bax and Bcl-x expression following kainic acid administration at convulsant doses in the rat. Neuroscience 1999; 91: 1461-1470.
89. Li TF, Lu CZ, Xia ZL, Niu JZ, Yang MF, Luo YM and Hong Z. Dephosphorelation of Bad and upregulation of Bcl-2 in hippocampus of rats following limbic seizure induced by kainic acid injection into amygdaloid nucleus. Sheng Li Xue Bao 2005; 57: 310-318.
90. Shinoda S, Schindler CK, Lan J-Q, Saugstad JA, Taki W, Simon RP and Henshall DC. Interaction of 14-3-3 with Bid during seizure-induced neuronal death. J Neurochem 2003; 86: 460-469.
91. Phillips RG, Lawrence MS, Ho DY and Sapolsky RM. Limitations in the neuroprotective potential of gene therapy with Bcl-2. Brain Res 2000; 859: 202-206.
92. Ju KL, Manley NC and Sapolsky RM. Anti-apoptotic therapy with a Tat fusion protein protects against excitotoxic insults in vitro and in vivo. Exp Neurol 2008; 210: 602-607.
93. Fannjiang Y, Kim CH, Huganir RL, Zou S, Lindsten T, Thompson CB, Mito T, Traystman RJ, Larsen T, Griffin DE, Mandir AS, Dawson TM, Dike S, Sappington AL, Kerr DA, Jonas EA, Kaczmarek LK and Hardwick JM. BAK alters neuronal excitability and can switch from antito pro-death function during postnatal development. Dev Cell 2003; 4: 575-585.
94. Concannon CG, Ward MW, Bonner HP, Kuroki K, Tuffy LP, Bonner CT, Woods I, Engel T, Henshall DC and Prehn JH. NMDA receptor-mediated excitotoxic neuronal apoptosis in vitro and in vivo occurs in an ER Stress and PUMA independent manner. J Neurochem 2007;
95. Theofilas P, Bedner P, Huttmann K, Theis M, Steinhauser C and Frank S. The proapoptotic BCL-2 homology domain 3-only protein Bim is not critical for acute excitotoxic cell death. J Neuropathol Exp Neurol 2009; 68: 102-110.
96. Shinoda S, Skradski SL, Araki T, Schindler CK, Meller R, Lan J-Q, Taki W, Simon RP and Henshall DC. Formation of a tumour necrosis factor receptor 1 molecular scaffolding complex and activation of apoptosis signal-regulating kinase 1 during seizure-induced neuronal death. Eur J Neurosci 2003; 17: 2065-2076.
97. Henshall DC, Araki T, Schindler CK, Shinoda S, Lan J-Q and Simon RP. Expression of death-associated protein kinase and recruitment to the tumor necrosis factor signaling pathway following brief seizures. J. Neurochem. 2003; 86: 1260-1270.
98. Meller R, Clayton C, Torrey DJ, Schindler CK, Lan JQ, Cameron JA, Chu XP, Xiong ZG, Simon RP and Henshall DC. Activation of the caspase 8 pathway mediates seizure-induced cell death in cultured hippocampal neurons. Epilepsy Res 2006; 70: 3-14.
99. Dorr J, Bechmann I, Waiczies S, Aktas O, Walczak H, Krammer PH, Nitsch R and Zipp F. Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain. J Neurosci 2002; 22: RC209.
100. Yamamoto A, Schindler CK, Murphy BM, Bellver-Estelles C, So NK, Taki W, Meller R, Simon RP and Henshall DC. Evidence of tumor necrosis factor receptor 1 signaling in human temporal lobe epilepsy. Exp Neurol 2006; 202: 410-420.
101. Gary DS, Bruce-Keller AJ, Kindy MS and Mattson MP. Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor. J Cereb Blood Flow Metab 1998; 18: 1283-1287.
102. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM and Kroemer G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999; 397: 441-446.
103. Cregan SP, Dawson VL and Slack RS. Role of AIF in caspase-dependent and caspase-independent cell death. Oncogene 2004; 23: 2785-2796.
104. Wang H, Yu SW, Koh DW, Lew J, Coombs C, Bowers W, Federoff HJ, Poirier GG, Dawson TM and Dawson VL. Apoptosis-inducing factor substitutes for caspase executioners in NMDA-triggered excitotoxic neuronal death. J Neurosci 2004; 24: 10963-10973.
105. Zhang X, Chen J, Graham SH, Du L, Kochanek PM, Draviam R, Guo F, Nathaniel PD, Szabo C, Watkins SC and Clark RS. Intranuclear localization of apoptosis-inducing factor (AIF) and large scale dna fragmentation after traumatic brain injury in rats and in neuronal cultures exposed to peroxynitrite. J Neurochem 2002; 82: 181-191.
106. Slemmer JE, Zhu C, Landshamer S, Trabold R, Grohm J, Ardeshiri A, Wagner E, Sweeney MI, Blomgren K, Culmsee C, Weber JT and Plesnila N. Causal role of apoptosis-inducing factor for neuronal cell death following traumatic brain injury. Am J Pathol 2008; 173: 1795-1805.
107. Landshamer S, Hoehn M, Barth N, Duvezin-Caubet S, Schwake G, Tobaben S, Kazhdan I, Becattini B, Zahler S, Vollmar A, Pellecchia M, Reichert A, Plesnila N, Wagner E and Culmsee C. Bid-induced release of AIF from mitochondria causes immediate neuronal cell death. Cell Death Differ 2008; 15: 1553-1563.
108. Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, Poirier GG, Dawson TM and Dawson VL. Mediation of poly(ADPribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 2002; 297: 259-263.
109. Polster BM, Basanez G, Etxebarria A, Hardwick JM and Nicholls DG. Calpain I induces cleavage and release of apoptosis-inducing factor from isolated mitochondria. J Biol Chem 2005; 280: 6447-6454.
110. Cao G, Xing J, Xiao X, Liou AK, Gao Y, Yin XM, Clark RS, Graham SH and Chen J. Critical role of calpain I in mitochondrial release of apoptosis-inducing factor in ischemic neuronal injury. J Neurosci 2007; 27: 9278-9293.
111. Haydon PG and Carmignoto G. Astrocyte control of synaptic transmission and neurovascular coupling. Physiol Rev 2006; 86: 1009-1031.
112. Li T, Quan Lan J, Fredholm BB, Simon RP and Boison D. Adenosine dysfunction in astrogliosis: cause for seizure generation? Neuron Glia Biol 2007; 3: 353-366.
113. Vezzani A, Ravizza T, Balosso S and Aronica E. Glia as a source of cytokines: implications for neuronal excitability and survival. Epilepsia 2008; 49 Suppl 2: 24-32.
114. Ferrer I, Lopez E, Blanco R, Rivera R, Krupinski J and Marti E. Differential c-Fos and caspase expression following kainic acid excitotoxicity. Acta Neuropathol (Berl) 2000; 99: 245-256.
115. Gillardon F, Bottiger B, Schmitz B, Zimmermann M and Hossmann K-A. Activation of CPP32 protease in hippocampal neurons following ischemia and epilepsy. Mol. Brain Res. 1997; 50: 16-22.
116. Faherty CJ, Xanthoudakis S and Smeyne RJ. Caspase-3-dependent neuronal death in the hippocampus following kainic acid treatment. Brain Res. Mol. Brain Res. 1999; 70: 159-163.
117. Li TF, Luo YM and Lu CZ. The expression of Smac and XIAP in rat hippocampus following limbic seizure induced by kainic acid injection into amygdaloid nucleus. Sheng Li Xue Bao 2004; 56: 172-177.
118. Bechmann I, Mor G, Nilsen J, Eliza M, Nitsch R and Naftolin F. FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: evidence for the existence of an immunological brain barrier. Glia 1999; 27: 62-74.
119. Ravizza T, Rizzi M, Perego C, Richichi C, Veliskova J, Moshe SL, De Simoni MG and Vezzani A. Inflammatory response and glia activation in developing rat hippocampus after status epilepticus. Epilepsia 2005; 46 Suppl 5: 113-117.
120. Ravizza T, Noe F, Zardoni D, Vaghi V, Sifringer M and Vezzani A. Interleukin Converting Enzyme inhibition impairs kindling epileptogenesis in rats by blocking astrocytic IL-1beta production. Neurobiol Dis 2008; 31: 327-333.
121. Lorigados Pedre L, Orozco Suarez S, Morales Chacon L, Garcia Maeso I, Estupinan Diaz B, Bender del Busto JE, Pavon Fuentes N, Paula Pinero B and Rocha Arrieta L. Neuronal death in the neocortex of drug resistant temporal lobe epilepsy patients. Neurologia 2008; 23: 555-565.
122. Graham SH, Chen J, Stetler RA, Zhu RL, Jin KL and Simon RP. Expression of the proto-oncogene bcl-2 is increased in the rat brain following kainate-induced seizures. Rest Neurol Neurosci 1996; 9: 243-250.
123. Korhonen L, Belluardo N, Mudo G and Lindholm D. Increase in Bcl-2 phosphorylation and reduced levels of BH3-only Bcl-2 family proteins in kainic acid-mediated neuronal death in the rat brain. Eur J Neurosci 2003; 18: 1121-1134.
124. Henshall DC, Skradski SL, Lan J, Ren T and Simon RP. Increased Bcl-w expression following focally evoked limbic seizures in the rat. Neurosci Lett 2001; 305: 153-156.
125. Yang J, Huang Y, Yu X, Sun H, Li Y and Deng Y. Erythropoietin preconditioning suppresses neuronal death following status epilepticus in rats. Acta Neurobiol Exp (Wars) 2007; 67: 141-148.
126. Noh HS, Kim YS, Kim YH, Han JY, Park CH, Kang AK, Shin HS, Kang SS, Cho GJ and Choi WS. Ketogenic diet protects the hippocampus from kainic acid toxicity by inhibiting the dissociation of bad from 14-3-3. J Neurosci Res 2006; 84: 1829-1836.